20-3471244-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_139321.3(ATRN):c.137G>A(p.Gly46Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000166 in 1,445,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_139321.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATRN | NM_139321.3 | c.137G>A | p.Gly46Glu | missense_variant | 1/29 | ENST00000262919.10 | |
ATRN | NM_001323332.2 | c.137G>A | p.Gly46Glu | missense_variant | 1/26 | ||
ATRN | NM_139322.4 | c.137G>A | p.Gly46Glu | missense_variant | 1/25 | ||
ATRN | NM_001207047.3 | c.62+110G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATRN | ENST00000262919.10 | c.137G>A | p.Gly46Glu | missense_variant | 1/29 | 5 | NM_139321.3 | P2 | |
ATRN | ENST00000446916.2 | c.137G>A | p.Gly46Glu | missense_variant | 1/25 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152104Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000216 AC: 1AN: 46334Hom.: 0 AF XY: 0.0000372 AC XY: 1AN XY: 26866
GnomAD4 exome AF: 0.00000232 AC: 3AN: 1293756Hom.: 0 Cov.: 32 AF XY: 0.00000315 AC XY: 2AN XY: 635802
GnomAD4 genome AF: 0.000138 AC: 21AN: 152104Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.137G>A (p.G46E) alteration is located in exon 1 (coding exon 1) of the ATRN gene. This alteration results from a G to A substitution at nucleotide position 137, causing the glycine (G) at amino acid position 46 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 30, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 46 of the ATRN protein (p.Gly46Glu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ATRN-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at